PreveCeutical Medical (PREV) Financial Statements

12 Followers

PreveCeutical Medical Financial Overview

PreveCeutical Medical's market cap is currently C$11.74M. The company's EPS TTM is C$0.0006; its P/E ratio is -8.98; PreveCeutical Medical is scheduled to report earnings on May 1, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Mar 24	Mar 23	Dec 21
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -14.43K	C$ -10.10K	C$ -9.86K	C$ -9.89K	C$ -5.09K
Operating Income	C$ -3.37M	C$ -812.47K	C$ -963.12K	C$ -1.10M	C$ -897.85K
EBITDA	C$ -3.35M	C$ -837.46K	C$ -955.09K	C$ -1.23M	C$ -829.83K
Net Income	C$ -1.58M	C$ -1.17K	C$ -1.27M	C$ -1.48M	C$ -1.73M
Balance Sheet
Cash & Short-Term Investments	C$ 10.24K	C$ 59.14K	C$ 1.43K	C$ 5.62K	C$ 16.06K
Total Assets	C$ 1.45M	C$ 225.66K	C$ 181.51K	C$ 189.14K	C$ 161.20K
Total Debt	C$ 4.68M	C$ 4.46M	C$ 3.83M	C$ 3.23M	C$ 2.93M
Net Debt	C$ 4.67M	C$ 4.40M	C$ 3.83M	C$ 3.23M	C$ 2.91M
Total Liabilities	C$ 7.69M	C$ 6.86M	C$ 5.96M	C$ 4.82M	C$ 4.27M
Stockholders' Equity	C$ -6.24M	C$ -6.64M	C$ -5.78M	C$ -4.64M	C$ -4.10M
Cash Flow
Free Cash Flow	C$ -1.72M	C$ -428.49K	C$ -296.97K	C$ -222.64K	C$ -481.59K
Operating Cash Flow	C$ -1.72M	C$ -426.69K	C$ -296.97K	C$ -222.64K	C$ -426.39K
Investing Cash Flow	C$ -2.96K	C$ -1.80K	C$ 0.00	C$ 850.00	C$ -52.70K
Financing Cash Flow	C$ 1.68M	C$ 487.64K	C$ 293.62K	C$ 211.72K	C$ 136.75K

Currency in CAD

PreveCeutical Medical Earnings and Revenue History

Income Statement >

PreveCeutical Medical Debt to Assets

Balance Sheet >

PreveCeutical Medical Cash Flow

Cash Flow >

PreveCeutical Medical Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >